We are live on ! Find out more
RMCM

Reynders McVeigh Capital Management Portfolio holdings

AUM $1.98B
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
+16.15%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$1.46B
AUM Growth
+$167M
Cap. Flow
-$8.4M
Cap. Flow %
-0.57%
Top 10 Hldgs %
35.83%
Holding
239
New
15
Increased
78
Reduced
108
Closed
17

Top Buys

Rank Stock Value
1
BXP icon
Boston Properties
BXP
+$4.35M
2
TMUS icon
T-Mobile US
TMUS
+$3.13M
3
CARR icon
Carrier Global
CARR
+$2.8M
4
UL icon
Unilever
UL
+$1.64M
5
MDT icon
Medtronic
MDT
+$1.58M

Top Sells

Rank Stock Value
1
FISV
Fiserv Inc
FISV
+$6.17M
2
TSLA icon
Tesla
TSLA
+$2.32M
3
DIS icon
Walt Disney
DIS
+$2.32M
4
AAPL icon
Apple
AAPL
+$1.66M
5
NKE icon
Nike
NKE
+$1.45M

Sector Composition

Rank Sector Weight
1 Healthcare 25.97%
2 Technology 19.63%
3 Industrials 12.26%
4 Communication Services 11.47%
5 Consumer Discretionary 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MKTX icon
26
MarketAxess Holdings
MKTX
$5.72B
$20.5M 1.4%
36,003
-169
-0.5% -$92.1K
BDX icon
27
Becton Dickinson
BDX
$49.8B
$20.2M 1.38%
82,560
+3,515
+4% +$820K
ADP icon
28
Automatic Data Processing
ADP
$106B
$19.6M 1.34%
111,505
+8,083
+8% +$1.33M
JNJ icon
29
Johnson & Johnson
JNJ
$629B
$19.3M 1.32%
122,823
+1,478
+1% +$218K
NVS icon
30
Novartis
NVS
$290B
$18.4M 1.26%
194,942
-5,240
-3% -$458K
CVS icon
31
CVS Health
CVS
$121B
$17.7M 1.21%
259,074
+1,979
+0.8% +$129K
PG icon
32
Procter & Gamble
PG
$336B
$16.2M 1.11%
116,644
-3,794
-3% -$530K
VEEV icon
33
Veeva Systems
VEEV
$38.9B
$15.3M 1.04%
56,068
-1,714
-3% -$480K
WM icon
34
Waste Management
WM
$90.5B
$14.9M 1.02%
126,547
+4,428
+4% +$516K
TMUS icon
35
T-Mobile US
TMUS
$190B
$14.5M 0.99%
107,241
+25,345
+31% +$3.13M
FISV
36
Fiserv Inc
FISV
$27.2B
$13.6M 0.93%
119,586
-57,266
-32% -$6.17M
SBUX icon
37
Starbucks
SBUX
$123B
$13.3M 0.91%
123,863
+3,525
+3% +$337K
NVO
38
Novo Nordisk
NVO
$202B
$12.5M 0.85%
358,108
+19,542
+6% +$675K
APH icon
39
Amphenol
APH
$209B
$11.3M 0.77%
344,324
+15,684
+5% +$482K
SYY icon
40
Sysco
SYY
$40.6B
$11.1M 0.76%
149,562
+20,696
+16% +$1.42M
TJX icon
41
TJX Companies
TJX
$169B
$11M 0.75%
160,878
-2,060
-1% -$125K
HD icon
42
Home Depot
HD
$344B
$10.9M 0.75%
41,160
+4,042
+11% +$1.11M
ORA icon
43
Ormat Technologies
ORA
$6.94B
$6.39M 0.44%
70,755
+787
+1% +$59.6K
TMO icon
44
Thermo Fisher Scientific
TMO
$223B
$6.11M 0.42%
13,110
-14
-0.1% -$6.56K
BEAM icon
45
Beam Therapeutics
BEAM
$2.77B
$5.61M 0.38%
68,689
+9,828
+17% +$483K
MRK icon
46
Merck
MRK
$330B
$5.58M 0.38%
71,503
-1,953
-3% -$149K
V icon
47
Visa
V
$673B
$5.48M 0.37%
25,051
+487
+2% +$99.7K
ABBV icon
48
AbbVie
ABBV
$440B
$5.44M 0.37%
50,756
-1,219
-2% -$117K
META icon
49
Meta Platforms (Facebook)
META
$1.48T
$5.21M 0.36%
19,069
-4,505
-19% -$1.24M
BXP icon
50
Boston Properties
BXP
$10.9B
$5.2M 0.36%
55,033
+48,713
+771% +$4.35M
1
2
3 4 5

Similar funds

SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
MYAM
Meiji Yasuda Asset Management Tokyo, Japan $2B AUM 22.52% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
C
Consulta London, United Kingdom $2.01B AUM 16.82% 1-Year Est. Return

Reynders McVeigh Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Reynders McVeigh Capital Management held 239 positions worth $1.46B, up 13% from $1.3B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Reynders McVeigh Capital Management's Q4 2020 filing shows 15 new, 78 increased, 108 reduced and 17 closed positions. Its largest new stake was Pacific Biosciences: 68,130 shares worth $1.77M. The largest sale was Fiserv Inc, an estimated $6.17M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 27% a quarter earlier, followed by Technology and Industrials.

  • Reynders McVeigh Capital Management's largest Q4 2020 buy was Pacific Biosciences: 68,130 shares worth $1.77M.
  • Reynders McVeigh Capital Management added most to Boston Properties in Q4 2020, an estimated $4.35M increase.
  • Reynders McVeigh Capital Management's biggest Q4 2020 reduction was Fiserv Inc, cutting an estimated $6.17M.
  • Reynders McVeigh Capital Management fully exited VF Corp in Q4 2020, selling an estimated $1.16M.
  • Reynders McVeigh Capital Management's ten largest holdings make up 36% of its $1.46B portfolio in Q4 2020.
  • Reynders McVeigh Capital Management opened 15 new positions and closed 17 in Q4 2020.
  • Reynders McVeigh Capital Management's portfolio value rose 13% quarter-over-quarter to $1.46B.

Based on Reynders McVeigh Capital Management's 13F filing for Q4 2020, filed 10 Feb 2021.